Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 01/08/21

Maria Gema Martin Manso, Ph.D.

Regulatory Affairs Manager

Dr. Maria Gema Martin Manso joined the Drug Regulatory Section of the Regulatory Affairs Branch (RAB) at CTEP in Oct. 2021. She comes from the FDA where she served as a Pharmaceutical Quality Assessor since 2016 in the Division of Biotechnology Manufacturing and Division of Microbiology Assessment, in the Office of Pharmaceutical Quality within the Center for Drug Evaluation and Research (CDER). Prior to joining the FDA, she spent two years as a Staff Scientist in the Program for Cell Enhancement and Technologies for Immunotherapy at Children’s National Research Institute (Washington, DC) where she was responsible for the CGMP-compliant expansion of cytotoxic T lymphocytes for immunotherapies. In addition, she spent nine years as a Research Fellow in the NCI Laboratory of Pathology, Center for Cancer Research where she conducted research in the field of Molecular and Cell Biology of cancer and the tumor microenvironment with a focus on tumor immunology and immunotherapy. Dr. Martin Manso received her Ph.D. and M.S. in Biochemistry and Molecular Biology and her B.S. in Neurobiology from the Complutense University of Madrid, Spain.

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…